Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.

CONCLUSIONS: Wee1 is frequently expressed in ovarian serous carcinoma effusions, and its expression is significantly higher following exposure to chemotherapy. The present study is the first to report that Wee1 is an independent prognostic marker in serous ovarian carcinoma.
PMID: 25093290 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - August 2, 2014 Category: Cancer & Oncology Authors: Slipicevic A, Holth A, Hellesylt E, Tropé CG, Davidson B, Flørenes VA Tags: Gynecol Oncol Source Type: research